Honor Officially Enters the Robot Business, Claims Record-Breaking SpeedChina Robotics Tech in Chinadiversification, Honor, R&D, Robotics May 28, 2025
China’s Innovative Medicine Sector is Booming: Why 2025 Could Be a Goldmine for InvestorsChina Finance Tech in ChinaBiotechnology, BOC Innovative Healthcare Fund, Changcheng Yiyao Chanye Jingxuan Fund, Haichen Yaoye, Healthcare Investment, Innovative Medicine, Luye Zhiyao, Ping'an Yiyao Jingxuan Gupiao, R&D, Taige Yiyao, Yongying Pharmaceutical Innovation Smart Selection Fund, Zhaoyan Xinyao, Zhongsheng Yaoye May 24, 2025
CATL’s Blockbuster Hong Kong IPO: Powering the Future with a Potential $5 Billion ListingChina Finance China VehiclesBatteries, CATL, China International Capital Corporation Hong Kong Securities Limited, CSCI (International) Finance Company Limited, Energy Storage, Goldman Sachs (Asia) L.L.C., Hong Kong IPO, Morgan Stanley Asia Limited, R&D, Securities Daily, Stellantis, Volkswagen Group May 6, 2025
STAR Market Pharma 2024 Report Card: Profit Growth for 53%, R&D Spend Hits ¥350M AverageChina Finance Tech in ChinaBeiGene, Biopharma, BioRay Pharmaceutical, EndoPuls Therapeutics, Jiangsu Jindiaok Biotechnology, Junshi Biosciences, Kexing Biopharm, Medicilon, MicroPort EP, Nansin Pharm, Notta & Belle, Profitability, R&D, RemeGen, SinoCellTech, STAR Market, Sunny Pharmatech, Sunshine Guojian Pharmaceutical, Tinavi Medical Technologies, United Imaging Healthcare, Xiangyu Medical, Zhixiang Bio May 6, 2025
